Cite Filings / ARWR / 0001564590-20-022860
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

ARROWHEAD PHARMACEUTICALS, INC. · Filed 2020-05-07 · Acc 0001564590-20-022860

Documents 1

  • 10-Q Quarterly Report , arwr-10q_20200331.htm

Around this filing

  • 2020-08-05 10-Q Quarterly Report
  • 2020-05-13 4 Director sold 36,000 shares at an average $35.83 ($1,289,891)
  • 2020-05-13 4 Director sold 26,000 shares at $36.54 ($950,040)
  • 2020-05-07 10-Q Quarterly Report
  • 2020-05-07 8-K Results of operations
  • 2020-05-01 8-K Executive or director change
  • 2020-02-05 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading arwr-10q_20200331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…